BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.17.5.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Global Biodefense
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20221030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20210504T160000
DTEND;TZID=America/Los_Angeles:20210504T180000
DTSTAMP:20240623T231246Z
CREATED:20210225T161815Z
LAST-MODIFIED:20240623T231246Z
UID:48633-1620144000-1620151200@globalbiodefense.com
SUMMARY:Reporting Science to Public & How 'Science' Adapts to the Pandemic
DESCRIPTION:A virtual presentation on “Reporting Science to Public & How ‘Science’ Adapts to the Pandemic” will be held on May 4\, 2021 as part of the 2021 Demystifying Medicine Series. \nThe 2021 Demystifying Medicine Series\, which is jointly sponsored by FAES and NIH\, will begin January 12 and includes the presentation of patients\, pathology\, diagnosis and therapy in the context of major disease problems and current research. Primarily directed toward Ph.D. students\, clinicians and program managers\, the course is designed to help bridge the gap between advances in biology and their application to major human diseases. Each session includes clinical and basic science components presented by NIH staff and invitees. All students\, fellows and staff are welcome\, as well. \nAbout the Speakers \n~ Stephen Smith (Washington Post Health and Science Editor) \n~ Valda Vinson\, PhD (Science Editor) – Valda Vinson is Editor (Research) at Science. She came to the United States as a Fulbright scholar and after completing a Ph.D and post-doctoral studies\, spent 2 years as a Senior Lecturer at the University of the Western Cape. She started her career in publishing when she joined the Science staff in 1999. Since then\, she has handled research papers in the areas of structural biology\, biochemistry\, and biophysics as an Associate and Senior Editor. In 2013 Dr. Vinson became Deputy Editor\, overseeing research content in the areas of cellular and molecular biology and biomedicine\, and in 2018 was named Editor\, Research. As Editor she works with Life Science editors to attract and select exciting research papers and reviews\, while following standards that support transparency and reproducibility. She also works with others on the editorial management team on editorial policies at Science and is involved in initiatives that bring together stake-holders within the publishing industry to discuss policies. \nPlease visit the NIH Demystifying Medicine website for more information.
URL:https://globalbiodefense.com/event/reporting-science-to-public-how-science-adapts-to-the-pandemic/
CATEGORIES:Government Hosted,Webinar-Webcast,Workshop
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210511T110000
DTEND;TZID=America/New_York:20210511T150000
DTSTAMP:20201127T193923Z
CREATED:20201127T193923Z
LAST-MODIFIED:20201127T193923Z
UID:48065-1620730800-1620745200@globalbiodefense.com
SUMMARY:Envisioning a Transformed Clinical Trials Enterprise for 2030 - Session 4
DESCRIPTION:The National Academies’ Forum on Drug Discovery\, Development\, and Translation will host a virtual public workshop on May 11\, 2021 as part of a web series forum of events to discuss critical policy for advancement of biopharmaceutical innovation nationally and globally. \nThis virtual public workshop will provide a venue for stakeholders to consider a transformed clinical trial enterprise for 2030. Workshop participants will consider lessons learned from progress and setbacks over the past 10 years\, since the previous workshop\, Envisioning a Transformed Clinical Trials Enterprise in the United States\, and\, looking forward\, discuss goals and key priorities for advancing a clinical trials enterprise that is more efficient\, effective\, person-centered\, inclusive\, and integrated into the health delivery system of 2030. \nThe event will consider ways the thoughtful and deliberate use of new technologies could improve the clinical trials enterprise and support goals outline in prior webinar sessions. \nBackground\nClinical trials research has changed dramatically over the last decade. The biological\, physical\, and digital spheres are merging; clinical research and health care are at a critical juncture; new approaches enable the collection of data in real-world settings; and new modalities\, such as digital health technologies and artificial intelligence applications\, are changing possibilities for the conduct of clinical research. \nA planning committee of the National Academies of Sciences\, Engineering\, and Medicine will plan and conduct a virtual public workshop designed to consider a transformed clinical trial enterprise for 2030. Key priority challenges and opportunities framing the 2030 agenda are: \n\nDiversity and inclusion of clinical trial participants\nConvergence of clinical research and clinical practice\nClinical trial data sharing\nIncorporation of new technologies into drug research and development\nWorkforce and career development\nPublic engagement and partnership\nRegulatory Environment\nCultural and Financial Incentives\nPractical short- and long-term goals for improving the efficiency\, effectiveness\, person-centeredness\, inclusivity\, and integration with healthcare of the clinical trials enterprise.\n\nPlanning Committee\n\nSteven Galson (Co-Chair)\, Amgen\nEster Krofah (Co-Chair)\, FasterCures\, Milken Institute\nAmy Abernethy\, Office of the Comissioner\, FDA\nAnita LaFrance Allen\, University of Pennsylvania\nChristopher P. Austin\, National Center for Advancing Translational Sciences\, NIH\nHoward A. Burris\, Sarah Cannon\nLuther T. Clark\, Merck & Co.\, Inc.\nGiselle Corbie-Smith\, The University of North Carolina at Chapel Hill\nM. Khair ElZarrad\, Center for Drug Evaluation and Research\, FDA\nJennifer Goldsack\, Digital Medicine Society\nRichard A. Moscicki\, PhRMA\nAmy Patterson\, National Heart\, Lung\, and Blood Institute\, NIH\nJoseph Scheeren\, Critical Path Institute\nAnantha Shekhar\, University of Pittsburgh\nPamela Tenaerts\, Clinical Trials Transformation Initiative\nChristopher Yoo\, Systems Oncology\n\nFor additional information on the workshop series\, please visit the project page.
URL:https://globalbiodefense.com/event/envisioning-a-transformed-clinical-trials-enterprise-for-2030-session-4/
CATEGORIES:Webinar-Webcast,Workshop
LOCATION:https://bit.ly/nasem-clinicaltrialenterprise
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210518
DTEND;VALUE=DATE:20210519
DTSTAMP:20210518T222659Z
CREATED:20210318T222200Z
LAST-MODIFIED:20210518T222659Z
UID:49251-1621296000-1621382399@globalbiodefense.com
SUMMARY:CBRNE Research and Innovation 2021
DESCRIPTION:The International e-Conference on CBRNE Research & Innovation will take place May 18\, 2021. \nHighlighted topics include: \n\nRecycling protective garments processes and techniques used for decontaminating and removing unwanted organic substances\nOnline tools for assessment of factors associated with SARS-CoV-2 infection\, and evaluation of new prophylactic and therapeutic drug regimens against COVID-19\nDiscovery tools in preparedness and response to NRBC threats\nPReparedness against CBRNE threats through cOmmon Approaches between security praCTItioners and the VulnerablE civil society (PROACTIVE)\nEuropean Network of CBRN Training Centers: just-in-time training and evolving training methodologies for first responders\n\nThe virtual format event builds on the success of the first 3 international conferences which tool place in Antibes (2015)\, Lyon (2017) and Nantes (2019) and will serve as a professional bridge until the next in-person conference at Lille in May 2022. \nhttps://cbrneconference.fr/ \n  \n 
URL:https://globalbiodefense.com/event/cbrne-research-and-innovation-2021/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:https://cbrneconference.fr/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210520T090000
DTEND;TZID=America/New_York:20210520T110000
DTSTAMP:20210520T140902Z
CREATED:20210501T140556Z
LAST-MODIFIED:20210520T140902Z
UID:49256-1621501200-1621508400@globalbiodefense.com
SUMMARY:The Future of Global Health Security
DESCRIPTION:Join Dr. Tom Frieden and the Prevent Epidemics team of Resolve to Save Lives\, an initiative of Vital Strategies\, to discuss lessons from past outbreaks\, preparedness successes\, and the need to invest and prioritize funding to fight the next pandemic. The event will call on political and public health leaders to increase global collaboration and work together at the global\, regional\, country\, and local levels to build a more resilient response to future health emergencies. For more information pandemic preparedness\, read our recent report Epidemics that Didn’t Happen.
URL:https://globalbiodefense.com/event/the-future-of-global-health-security/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:https://preventepidemics.org/globalhealthsecurityevent/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210526T110000
DTEND;TZID=America/New_York:20210526T120000
DTSTAMP:20210525T214033Z
CREATED:20210516T211111Z
LAST-MODIFIED:20210525T214033Z
UID:49261-1622026800-1622030400@globalbiodefense.com
SUMMARY:U.S. Leadership for a Pandemic-Free Future: Technologies to End Biological Threats
DESCRIPTION:The Capitol Hill Steering Committee on Pandemic Preparedness and Health Security will convene for a webcast event on “U.S. Leadership for a Pandemic-Free Future: Technologies to End Biological Threats” on Wednesday\, May 26\, 2021. \nThis webinar will explore how the federal government can prioritize investments in available and future technologies to ensure nothing like the Covid-19 pandemic\, or worse\, could ever happen again. \nThe Steering Committee hosts monthly events focused on lessons learned from responses to natural\, man-made\, and other complex health emergencies\, such as the COVID-19 pandemic\, and how to better mitigate and respond to future health crises. \nThe Steering Committee is sponsored and managed by Johns Hopkins Center for Health Security. Six United States Senators serve as Honorary Senate Co-Chairs\, Four United States House of Representatives serve as Honorary House Co-Chairs and 4 former federal government public health leaders serve as Honorary Founding Members. \nHonorary Senate Co-Chairs \n\nSenator Tammy Baldwin (D-WI)\nSenator Richard Burr (R-NC)\nSenator Ben Cardin (D-MD)\nSenator Bob Casey (D-PA)\nSenator Cindy Hyde-Smith (R-MS)\n\nSenator Chris Van Hollen (D-MD)\n\n\nHonorary House of Representatives Co-Chairs \n\nRepresentative Rosa DeLauro (D-CT)\nRepresentative Anna Eshoo (D-CA)\nRepresentative Andy Harris (R-MD)\nRepresentative Richard Hudson (R-NC)\n\nHonorary Founding Members \n\nSusan Brooks\, JD\, Former U.S. House of Representative (R-IN)\nStephen Redd\, MD\, Former Deputy Director for Public Health Service and Implementation Science\, US Centers for Disease Control and Prevention; Rear Admiral Retired\, US Public Health Service\nKathleen Sebelius\, MPA\, Former Secretary\, US Department of Health and Human Services\, former Governor of Kansas\nW. Craig Vanderwagen\, MD\, Former Assistant Secretary for Preparedness and Response\, US Department of Health and Human Services\, Rear Admiral Retired\, US Public Health Service
URL:https://globalbiodefense.com/event/u-s-leadership-for-a-pandemic-free-future-technologies-to-end-biological-threats/
LOCATION:https://jh.zoom.us/webinar/register/WN_bE6b6oFDSyS3C2a3WWEleA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20210527T133000
DTEND;TZID=Europe/Paris:20210527T144500
DTSTAMP:20210518T223618Z
CREATED:20210501T222833Z
LAST-MODIFIED:20210518T223618Z
UID:49253-1622122200-1622126700@globalbiodefense.com
SUMMARY:Advancing Gender Perspectives in the Biological Weapons Convention
DESCRIPTION:The International Gender Champions Disarmament Impact Group and the BWC Implementation Support Unit welcome you to an interactive discussion on 27 May on the relevance of gender perspectives to the implementation of the Biological Weapons Convention. \nThe discussion will address recent initiatives to improve women’s meaningful participation in the BWC\, as well as research on sex-specific and gendered impacts of biological weapons. \nPanelists will take stock of how gender perspectives are already being incorporated into BWC discussions and\, in view of the forthcoming Ninth BWC Review Conference\, how they can be further promoted and strengthened in future BWC work programmes. \nThe event will also mark the launch of a new factsheet by the Disarmament Impact Group on “Gender and Biological Weapons”. \n 
URL:https://globalbiodefense.com/event/advancing-gender-perspectives-in-the-biological-weapons-convention/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:https://rtce-unog.webex.com/mw3300/mywebex/default.do?nomenu=true&siteurl=rtce-unog&service=6&rnd=0.4655756273962446&main_url=https%3A%2F%2Frtce-unog.webex.com%2Fec3300%2Feventcenter%2Fevent%2FeventAction.do%3FtheAction%3Ddetail%26%26%26EMK%3D4832534b00000004346873833f32d707b10d18ee70fc3d5c8c3d215ec63e9ede0c9f7e79edd173a2%26siteurl%3Drtce-unog%26confViewID%3D194014003524017497%26encryptTicket%3DSDJTSwAAAAQm5DyOP2TNxCQgIiR4ZmkiGlbFK2NrgnXV1zaYNmQKdw2%26
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20210527T153000
DTEND;TZID=Europe/London:20210527T163000
DTSTAMP:20210518T201503Z
CREATED:20210518T201503Z
LAST-MODIFIED:20210518T201503Z
UID:49248-1622129400-1622133000@globalbiodefense.com
SUMMARY:Maximum Containment Labs Around the World
DESCRIPTION:Join Dr. Filippa Lentzos and Dr. Gregory D. Koblentz for a briefing on 27 May 2021 on a new resource on global BSL4 labs and biorisk management policies. \nThis public webinar\, held on the side lines of the seventy-fourth World Health Assembly meeting\, will launch globalbiolabs.org\, an interactive web-based map of global Biosafety Level-4 facilities and biorisk management policies. An accompanying policy brief\, entitled ‘Mapping Maximum Biological Containment Labs Globally’\, will also be released. \n 
URL:https://globalbiodefense.com/event/maximum-containment-labs-around-the-world/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:https://us02web.zoom.us/webinar/register/WN_HuZbZ7SbS8OvljyRYr9-nA
END:VEVENT
END:VCALENDAR